
7270.T vs PSNY

In the past 12 months, 7270.T returned -16% while PSNY lost 86%.
Valuation
Compare price multiples and valuation ratios
| Metric | 7270.T | PSNY | Winner |
|---|---|---|---|
P/E Ratio Price to earnings ratio | 22.26 | -0.22 | PSNY |
Forward P/E Forward price to earnings ratio | 0.00 | 0.00 | Tie |
P/S Ratio Price to sales ratio | 0.39 | 0.22 | PSNY |
P/B Ratio Price to book ratio | 0.68 | -0.11 | PSNY |
P/FCF Ratio Price to free cash flow ratio | 44.66 | -0.29 | PSNY |
EV/EBITDA Enterprise value to EBITDA | 3.66 | -5.71 | PSNY |
PEG Ratio Price/earnings to growth ratio | 0.00 | 0.00 | Tie |
Profitability
Compare profit margins and returns on capital
| Metric | 7270.T | PSNY | Winner |
|---|---|---|---|
Gross Margin Gross profit margin | 14.2% | -4.5% | 7270.T |
Operating Margin Operating profit margin | 2.9% | -52.3% | 7270.T |
Net Margin Net profit margin | 1.8% | -66.8% | 7270.T |
ROE Return on equity | 3.1% | 40.0% | PSNY |
ROA Return on assets | 1.6% | -56.0% | 7270.T |
ROIC Return on invested capital | 3.3% | -98.9% | 7270.T |
Growth
Compare revenue and earnings growth rates
| Metric | 7270.T | PSNY | Winner |
|---|---|---|---|
Revenue Growth (YoY) Year-over-year revenue growth | 2.1% | 50.3% | PSNY |
Revenue Growth (3Y) 3-year revenue CAGR | 8.2% | 7.8% | 7270.T |
Revenue Growth (5Y) 5-year revenue CAGR | 11.1% | 38.0% | PSNY |
EPS Growth (YoY) Year-over-year EPS growth | -72.6% | 12.4% | PSNY |
EPS Growth (3Y) 3-year EPS CAGR | -21.7% | 0.0% | PSNY |
EPS Growth (5Y) 5-year EPS CAGR | 4.7% | 0.0% | 7270.T |
Balance Sheet & Risk
Compare financial stability and debt levels
| Metric | 7270.T | PSNY | Winner |
|---|---|---|---|
Debt/Equity Debt to equity ratio | 0.13 | -1.27 | PSNY |
Current Ratio Current assets to current liabilities | 2.29 | 0.32 | 7270.T |
Quick Ratio Quick assets to current liabilities | 1.75 | 0.22 | 7270.T |
Interest Coverage EBIT to interest expense | 20.48 | -8.33 | 7270.T |
Beta Stock volatility vs market | 0.08 | 1.73 | 7270.T |
RIVN
STLA
7272.T